Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation (TAVI) - in Atrial Fibrillation

Next Previous
Trial Profile

Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation (TAVI) - in Atrial Fibrillation

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 20 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Edoxaban (Primary) ; Fluindione; Phenindione; Phenprocoumon; Vitamin K antagonists; Warfarin
  • Indications Embolism and thrombosis; Myocardial infarction; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ENVISAGE-TAVI AF
  • Sponsors Daiichi Sankyo Company; Daiichi Sankyo Inc

    • Most Recent Events

    • 13 Nov 2023 Results of post hoc sub-analysis assessing whether efficacy and safety of EDO vs VKA in patients with AF undergoing TAVR will vary across the range of baseline CrCl, presented at the American Heart Association Scientific Sessions 2023
    • 13 Nov 2023 Results analyzing association between anticoagulation treatment duration and patient-reported outcomes (PROs) and treatment satisfaction, presented at the American Heart Association Scientific Sessions 2023
    • 14 Oct 2023 Results of a Post Hoc Analysis comparing effects of Edoxaban and Vitamin K Antagonists in patients with Atrial Fibrillation after Transcatheter Aortic Valve Replacement, presented at the American Journal of Cardiology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top